Literature DB >> 30051357

De-escalation and discontinuation strategies in high-risk neutropenic patients: an interrupted time series analyses of antimicrobial consumption and impact on outcome.

Giulia la Martire1,2, Christine Robin3,4, Nadia Oubaya5, Raphaël Lepeule6, Florence Beckerich3,4, Mathieu Leclerc3,4, Walid Barhoumi3, Andréa Toma3, Cécile Pautas3, Sébastien Maury3,4, Wiem Akrout7, Catherine Cordonnier-Jourdin7, Vincent Fihman8,9, Mario Venditti10, Catherine Cordonnier3,4.   

Abstract

Febrile neutropenia (FN) is the main reason for antibiotic prescription in hematology wards where, on the other hand, antibiotic stewardship (AS) is poorly explored. The objectives of the present study were to evaluate (1) the impact of an AS intervention on antibiotic consumption and (2) the applicability and acceptance rate of the intervention and its clinical impact. A persuasive AS intervention based on European Conference on Infection in Leukaemia (ECIL) guidelines for FN was implemented in a high-risk hematology ward in a tertiary referral public university hospital. This included the creation and diffusion of flow charts on de-escalation and discontinuation of antibiotics for FN, and the introduction in the team of a doctor dedicated to the implementation of flow charts and to antibiotic prescription revision. All consecutive patients receiving antibiotics during hospitalization were included. A segmented linear regression model was performed for the evaluation of antibiotic consumption, taking into account 1-year pre-intervention period and 6-month intervention period. Overall, 137 consecutive antibiotic prescriptions were re-evaluated, 100 prescriptions were for FN. A significant reduction of the level of carbapenem consumption was observed during the intervention period (level change (estimate coefficient ± standard error) = - 135.28 ± 59.49; p = 0.04). Applicability and acceptability of flow charts were high. No differences in terms of intensive care unit transfers, bacteremia incidence, and mortality were found. A persuasive AS intervention in hematology significantly reduced carbapenem consumption without affecting outcome and was well accepted. This should encourage further applications of ECIL guidelines for FN.

Entities:  

Keywords:  Antibiotic consumption; Antimicrobial stewardship; Carbapenem; De-escalation; Febrile neutropenia; Interrupted time series

Mesh:

Substances:

Year:  2018        PMID: 30051357     DOI: 10.1007/s10096-018-3328-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  38 in total

1.  Antibiotic resistance-the need for global solutions.

Authors:  Ramanan Laxminarayan; Adriano Duse; Chand Wattal; Anita K M Zaidi; Heiman F L Wertheim; Nithima Sumpradit; Erika Vlieghe; Gabriel Levy Hara; Ian M Gould; Herman Goossens; Christina Greko; Anthony D So; Maryam Bigdeli; Göran Tomson; Will Woodhouse; Eva Ombaka; Arturo Quizhpe Peralta; Farah Naz Qamar; Fatima Mir; Sam Kariuki; Zulfiqar A Bhutta; Anthony Coates; Richard Bergstrom; Gerard D Wright; Eric D Brown; Otto Cars
Journal:  Lancet Infect Dis       Date:  2013-11-17       Impact factor: 25.071

Review 2.  From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel.

Authors: 
Journal:  J Infect Dis       Date:  1990-03       Impact factor: 5.226

3.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Authors:  Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079

4.  Discontinuation of antimicrobial therapy for febrile, neutropenic children with cancer: a prospective study.

Authors:  M E Santolaya; M Villarroel; L F Avendaño; J Cofré
Journal:  Clin Infect Dis       Date:  1997-07       Impact factor: 9.079

5.  A Simulation Study Reveals Lack of Pharmacokinetic/Pharmacodynamic Target Attainment in De-escalated Antibiotic Therapy in Critically Ill Patients.

Authors:  Mieke Carlier; Jason A Roberts; Veronique Stove; Alain G Verstraete; Jeffrey Lipman; Jan J De Waele
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

6.  De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study.

Authors:  Djamel Mokart; Géraldine Slehofer; Jérôme Lambert; Antoine Sannini; Laurent Chow-Chine; Jean-Paul Brun; Pierre Berger; Ségolène Duran; Marion Faucher; Jean-Louis Blache; Colombe Saillard; Norbert Vey; Marc Leone
Journal:  Intensive Care Med       Date:  2014-01       Impact factor: 17.440

7.  Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey.

Authors:  Enrico Maria Trecarichi; Livio Pagano; Bruno Martino; Anna Candoni; Roberta Di Blasi; Gianpaolo Nadali; Luana Fianchi; Mario Delia; Simona Sica; Vincenzo Perriello; Alessandro Busca; Franco Aversa; Rosa Fanci; Lorella Melillo; Federica Lessi; Maria Ilaria Del Principe; Chiara Cattaneo; Mario Tumbarello
Journal:  Am J Hematol       Date:  2016-07-29       Impact factor: 10.047

8.  Antimicrobial de-escalation in septic cancer patients: is it safe to back down?

Authors:  Alla Paskovaty; Stephen M Pastores; Zivile Gedrimaite; Natalie Kostelecky; Elyn R Riedel; Susan K Seo
Journal:  Intensive Care Med       Date:  2015-08-22       Impact factor: 17.440

9.  Metrics for quantifying antibiotic use in the hospital setting: results from a systematic review and international multidisciplinary consensus procedure.

Authors:  Mirjana Stanic Benic; Romina Milanic; Annelie A Monnier; Inge C Gyssens; Niels Adriaenssens; Ann Versporten; Veronica Zanichelli; Marion Le Maréchal; Benedikt Huttner; Gianpiero Tebano; Marlies E Hulscher; Céline Pulcini; Jeroen Schouten; Vera Vlahovic-Palcevski
Journal:  J Antimicrob Chemother       Date:  2018-06-01       Impact factor: 5.790

10.  DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?

Authors:  Jason A Roberts; Sanjoy K Paul; Murat Akova; Matteo Bassetti; Jan J De Waele; George Dimopoulos; Kirsi-Maija Kaukonen; Despoina Koulenti; Claude Martin; Philippe Montravers; Jordi Rello; Andrew Rhodes; Therese Starr; Steven C Wallis; Jeffrey Lipman
Journal:  Clin Infect Dis       Date:  2014-01-14       Impact factor: 9.079

View more
  12 in total

Review 1.  Microbiota-based approaches to mitigate infectious complications of intensive chemotherapy in patients with acute leukemia.

Authors:  Armin Rashidi; Daniel J Weisdorf
Journal:  Transl Res       Date:  2020-04-05       Impact factor: 7.012

2.  Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia.

Authors:  Jessica R Galloway-Peña; Yushu Shi; Christine B Peterson; Pranoti Sahasrabhojane; Vancheswaran Gopalakrishnan; Chelcy E Brumlow; Naval G Daver; Mansour Alfayez; Prajwal C Boddu; Md Abdul Wadud Khan; Jennifer A Wargo; Kim-Anh Do; Robert R Jenq; Dimitrios P Kontoyiannis; Samuel A Shelburne
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

3.  Persuasive antimicrobial stewardship intervention in the context of a KPC outbreak: a controlled interrupted time series analysis.

Authors:  Nuno Rocha-Pereira; Paulo Figueiredo Dias; Sofia Correia; Shirin Shahriari; João Neves; José Teixeira; José Artur Paiva; Carlos Lima Alves; Ana Azevedo
Journal:  Antimicrob Resist Infect Control       Date:  2020-04-21       Impact factor: 4.887

4.  Long-Term Impact of an Educational Antimicrobial Stewardship Program on Management of Patients with Hematological Diseases.

Authors:  Ana Belén Guisado-Gil; Manuela Aguilar-Guisado; Germán Peñalva; José Antonio Lepe; Ildefonso Espigado; Eduardo Rodríguez-Arbolí; José González-Campos; Nancy Rodríguez-Torres; María Isabel Montero-Cuadrado; José Francisco Falantes-González; Juan Luis Reguera-Ortega; María Victoria Gil-Navarro; José Molina; José-Antonio Pérez-Simón; José Miguel Cisneros
Journal:  Antibiotics (Basel)       Date:  2021-01-30

5.  Variation in Clinical Practice and Attitudes on Antibacterial Management of Fever and Neutropenia in Patients With Hematologic Malignancy: A Survey of Cancer Centers Across the United States.

Authors:  Jason N Barreto; Samuel L Aitken; Elizabeth M Krantz; Jerod L Nagel; Sanjeet S Dadwal; Susan K Seo; Catherine Liu
Journal:  Open Forum Infect Dis       Date:  2022-02-04       Impact factor: 4.423

6.  Safety and Efficacy of Antibiotic De-escalation and Discontinuation in High-Risk Hematological Patients With Febrile Neutropenia: A Single-Center Experience.

Authors:  Anke Verlinden; Hilde Jansens; Herman Goossens; Sébastien Anguille; Zwi N Berneman; Wilfried A Schroyens; Alain P Gadisseur
Journal:  Open Forum Infect Dis       Date:  2021-12-23       Impact factor: 3.835

7.  Antimicrobial stewardship in high-risk febrile neutropenia patients.

Authors:  Adrien Contejean; Salam Abbara; Ryme Chentouh; Sophie Alviset; Eric Grignano; Nabil Gastli; Anne Casetta; Lise Willems; Etienne Canouï; Caroline Charlier; Frédéric Pène; Julien Charpentier; Jeanne Reboul-Marty; Rui Batista; Didier Bouscary; Solen Kernéis
Journal:  Antimicrob Resist Infect Control       Date:  2022-03-26       Impact factor: 4.887

8.  Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome.

Authors:  F A Niessen; M S M van Mourik; A H W Bruns; R A P Raijmakers; M C H de Groot; T van der Bruggen
Journal:  Antimicrob Resist Infect Control       Date:  2020-05-27       Impact factor: 4.887

9. 

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-02       Impact factor: 1.513

10.  Impact of the multidisciplinary antimicrobial stewardship team intervention focusing on carbapenem de-escalation: A single-centre and interrupted time series analysis.

Authors:  Ayako Suzuki; Masayuki Maeda; Takuya Yokoe; Miyuki Hashiguchi; Mayumi Togashi; Keiko Ishino
Journal:  Int J Clin Pract       Date:  2020-09-18       Impact factor: 3.149

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.